UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Therapeutic advances in medical oncology, 2018-01, Vol.10, p.1758834017749748-1758834017749748

2018

Volltextzugriff (PDF)

Diffuse dermal mucinosis secondary to colony‐stimulating factor 1 receptor monoclonal antibody treatment: A novel and peculiar drug‐induced diffuse cutaneous mucinosis

Journal of dermatology, 2021-03, Vol.48 (3), p.380-384

2021

Volltextzugriff (PDF)

Bringing Model‐Based Prediction to Oncology Clinical Practice: A Review of Pharmacometrics Principles and Applications

The oncologist (Dayton, Ohio), 2016-02, Vol.21 (2), p.220-232

2016

Volltextzugriff (PDF)

Local and systemic diffusion of antineoplastic drugs following vertebroplasty using acrylic cement mixed with cisplatin or methotrexate: experimental study in pigs

European spine journal, 2017-12, Vol.26 (12), p.3216-3224

2017

Volltextzugriff (PDF)

Assessment of Epidermal Growth Factor Receptor and K‐Ras Mutation Status in Cytological Stained Smears of Non‐Small Cell Lung Cancer Patients: Correlation with Clinical Outcomes

The oncologist (Dayton, Ohio), 2011-01, Vol.16 (6), p.877-885

2011

Volltextzugriff (PDF)

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Cell, 2017-11, Vol.171 (4), p.934-949.e16

2017

Volltextzugriff (PDF)

Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)

Journal of clinical oncology, 2021-02, Vol.39 (6), p.586-598

2021

Volltextzugriff (PDF)

Dabrafenib in BRAF -mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

The Lancet (British edition), 2012-07, Vol.380 (9839), p.358-365

2012

Volltextzugriff (PDF)

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Journal of clinical oncology, 2021-08, Vol.39 (24), p.2656-2666

2021

Volltextzugriff (PDF)

Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients

Clinica chimica acta, 2014-02, Vol.429, p.168-174

2014

Volltextzugriff (PDF)

Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma

Archives of pathology & laboratory medicine (1976), 2014-06, Vol.138 (6), p.828-832

2014

Volltextzugriff (PDF)

Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice

Cancer research (Chicago, Ill.), 2015-09, Vol.75 (17), p.3466-3478

2015

Volltextzugriff (PDF)

Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

Clinical cancer research, 2014-11, Vol.20 (22), p.5697-5707

2014

Volltextzugriff (PDF)

Determinants of Toxicity, Patterns of Failure, and Outcome Among Adult Patients With Soft Tissue Sarcomas of the Extremity and Superficial Trunk Treated With Greater Than Conventional Doses of Perioperative High-Dose-Rate Brachytherapy and External Beam Radiotherapy

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.e529-e539

2011

Volltextzugriff (PDF)

Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2023-05, Vol.41 (14), p.2561-2570

2023

Volltextzugriff (PDF)

Sequence of therapies for advanced BRAFV600E/K melanoma

Annals of translational medicine, 2023-03, Vol.11 (6), p.270-270

2023

Volltextzugriff (PDF)

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

The oncologist (Dayton, Ohio), 2019-10, Vol.24 (10), p.1375-1383

2019

Volltextzugriff (PDF)

Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy

Scientific reports, 2020-05, Vol.10 (1), p.7478, Article 7478

2020

Volltextzugriff (PDF)

BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors

Melanoma research, 2015-12, Vol.25 (6), p.486-495

2015

Volltextzugriff (PDF)

Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program

Melanoma research, 2014-12, Vol.24 (6), p.577-583

2014

Volltextzugriff (PDF)

Special issue on II Translational Meeting from the Spanish Melanoma Group

Annals of translational medicine, 2017-10, Vol.5 (19), p.383-383

2017

Volltextzugriff (PDF)

Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert review

Critical reviews in oncology/hematology, 2013-02, Vol.85 (2), p.149-161

2013

Volltextzugriff (PDF)

A Population Pharmacodynamic Model for Lactate Dehydrogenase and Neuron Specific Enolase to Predict Tumor Progression in Small Cell Lung Cancer Patients

The AAPS journal, 2014-05, Vol.16 (3), p.609-619

2014

Volltextzugriff (PDF)

CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy

The Journal of immunology (1950), 2012-10, Vol.189 (7), p.3299-3310

2012

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(134)

Sprache

Englisch
(130)
Spanisch
(3)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(73)
Humans
(70)
Oncology
(52)
Female
(44)
Middle Aged
(44)
Male
(41)
Adult
(36)
Aged
(36)
Melanoma
(29)
Aged, 80 And Over
(19)
Treatment Outcome
(19)
Antineoplastic Agents - Therapeutic Use
(17)
Biological And Medical Sciences
(17)
Medical Sciences
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Melanoma - Drug Therapy
(15)
Survival Analysis
(14)
Retrospective Studies
(12)
Medicine
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Diffuse dermal mucinosis secondary to colony‐stimulating factor 1 receptor monoclonal antibody treatment: A novel and peculiar drug‐induced diffuse cutaneous mucinosis

Bringing Model‐Based Prediction to Oncology Clinical Practice: A Review of Pharmacometrics Principles and Applications

Local and systemic diffusion of antineoplastic drugs following vertebroplasty using acrylic cement mixed with cisplatin or methotrexate: experimental study in pigs

Assessment of Epidermal Growth Factor Receptor and K‐Ras Mutation Status in Cytological Stained Smears of Non‐Small Cell Lung Cancer Patients: Correlation with Clinical Outcomes

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)

Dabrafenib in BRAF -mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients

Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma

Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice

Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors

Determinants of Toxicity, Patterns of Failure, and Outcome Among Adult Patients With Soft Tissue Sarcomas of the Extremity and Superficial Trunk Treated With Greater Than Conventional Doses of Perioperative High-Dose-Rate Brachytherapy and External Beam Radiotherapy

Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung Cancer

Sequence of therapies for advanced BRAFV600E/K melanoma

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy

BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors

Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program

Special issue on II Translational Meeting from the Spanish Melanoma Group

Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert review

A Population Pharmacodynamic Model for Lactate Dehydrogenase and Neuron Specific Enolase to Predict Tumor Progression in Small Cell Lung Cancer Patients

CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy

Suchergebnisse filtern